Inclusion of MERS‐spike protein ELISA in algorithm to determine serologic evidence of MERS‐CoV infection

The Centers for Disease Control and Prevention (CDC) algorithm for detecting presence of serum antibodies against Middle East Respiratory Syndrome coronavirus (MERS‐CoV) in subjects with potential infections with the virus has included screening by indirect ELISA against recombinant nucleocapsid (N)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Med Virol
Päätekijät: Trivedi, Suvang, Miao, Congrong, Al‐Abdallat, Mohammad M., Haddadin, Aktham, Alqasrawi, Sultan, Iblan, Ibrahim, Nsour, Mohannad A., Alsanouri, Tarek, Ali, Sami S., Rha, Brian, Gerber, Susan I., Payne, Daniel C., Tamin, Azaibi, Thornburg, Natalie J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2017
Aiheet:
Short Communications
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6158782/
https://ncbi.nlm.nih.gov/pubmed/28906003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.24948
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia